This content is only available within our institutional offering.

03 Aug 2023
Hikma Pharmaceuticals: Strong H1 performance

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals: Strong H1 performance
Hikma Pharmaceuticals Plc (HIK:LON) | 1,720 -51.6 (-0.2%) | Mkt Cap: 3,816m
- Published:
03 Aug 2023 -
Author:
Paul Cuddon | Kane Slutzkin -
Pages:
4 -